South San Francisco, California 94080, United States
Thomas Rando, Joseph Rodgers
2018
50
Private company
11
Khosla Ventures
Altered intercellular communication
small molecule drugs
Fountain Therapeutics is building a pipeline of therapeutics to treat age-related diseases by reversing cellular age. The company has combined the expertise of leaders in aging research and computation to build an AI-driven platform that extracts previously hidden cellular features to measure aging with remarkable precision. Fountain is currently screening a large diversity of drug compounds, including small molecules and biologics, to identify novel drugs that specifically reverse the age of cells for the development of therapeutics to treat age-related diseases.